首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension
【24h】

Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension

机译:食管胶囊内镜检查对门静脉高压症患者食管静脉曲张的筛查和监测

获取原文
获取原文并翻译 | 示例
           

摘要

Bleeding from esophageal varices (EV) is a serious consequence of portal hypertension. Current guidelines recommend screening patients with cirrhosis with esophagogastroduodenoscopy (EGD) to detect varices. However, the unpleasantness and need for sedation of EGD may limit adherence to screening programs. Pilot studies have shown good performance of esophageal. capsule endoscopy in detecting varices. This multicenter trial was designed to assess the diagnostic performance of capsule endoscopy in comparison with EGD. Patients undergoing EGD for screening or surveillance of EV underwent a capsule study previously. The study was designed as an equivalence study, assuming that a difference of <= 10% between capsule endoscopy and EGD in diagnosing EV would demonstrate equivalence. Two hundred eighty-eight patients were enrolled. Endoscopy was for screening in 195 patients and for surveillance of known EV in 93. Overall agreement for detecting EV between EGD and capsule endoscopy was 85.8%; the kappa score was 0.73. Capsule endoscopy had a sensitivity, specificity, positive predictive value, and negative predictive value of 84%, 88%, 92%, and 77%, respectively. The difference in diagnosing EV was 15.6% in favor of EGD. There was complete agreement on variceal grade in 227 of 288 cases (79%). In differentiating between medium/large varices requiring treatment and small/absent varices requiring surveillance, the sensitivity, specificity, positive predictive value, and negative predictive value for capsule endoscopy were 78%, 96%, 87%, and 92%, respectively. Overall agreement on treatment decisions based on EV size was substantial at 91% (kappa = 0.77). Conclusion: We recommend that EGD be used to screen patients with cirrhosis for large EV. However, the minimal invasiveness, good tolerance, and good agreement of capsule endoscopy with EGD might increase adherence to screening programs. Whether this is the case needs to be determined.
机译:食管静脉曲张破裂出血是门脉高压的严重后果。目前的指南建议用食管胃十二指肠镜检查(EGD)筛查肝硬化患者以发现静脉曲张。但是,EGD的不愉快和镇静作用可能会限制对筛查程序的依从性。初步研究表明,食管具有良好的表现。胶囊内镜检查静脉曲张这项多中心试验旨在评估胶囊内镜与EGD的诊断性能。接受EGD筛查或监测EV的患者先前曾接受胶囊研究。该研究被设计为等效研究,假设胶囊内窥镜检查和EGD在诊断EV之间的差异<= 10%即可证明是等效的。招募了288名患者。内窥镜检查用于195例患者的筛查和93例已知EV的监测。在EGD和胶囊内窥镜检查之间检测EV的总体协议为85.8%;在EGD和胶囊内窥镜检查之间的总体一致性为85.8%。卡伯得分为0.73。胶囊内镜的敏感性,特异性,阳性预测值和阴性预测值分别为84%,88%,92%和77%。 EVG诊断EV的差异为15.6%。 288例病例中有227例完全同意了静脉曲张分级(79%)。在区分需要治疗的中/大静脉曲张与需要监测的小/无静脉曲张时,胶囊内镜的敏感性,特异性,阳性预测值和阴性预测值分别为78%,96%,87%和92%。根据电动车尺寸决定治疗方案的总体共识为91%(kappa = 0.77)。结论:我们建议使用EGD筛查肝硬化患者的大型EV。但是,胶囊内镜与EGD的微创性,良好的耐受性和良好的一致性可能会增加对筛查程序的依从性。是否需要确定这种情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号